Error Classification

The National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) ↗ classifies errors by severity:

A Circumstances that could cause error
B Error occurred, did not reach patient
C Reached patient, no harm
D Reached patient, monitoring required
E Temporary harm, intervention required
F Temporary harm, prolonged hospitalisation
G Permanent harm
H Life-threatening, intervention required
I Death

Categories A–B are near misses. C–I represent errors that reached the patient.

Types of Medication Error

Prescribing errors
Examples

Wrong dose, wrong drug, wrong indication, missing allergy check, failure to renally adjust.

Prevention

Clinical decision support (CDS) alerts in EMR, pharmacist order review, dose range checking.

Transcription errors
Examples

Decimal point errors (1.0 mg misread as 10 mg), trailing zeros, unclear abbreviations (U misread as 0).

Prevention

Ban dangerous abbreviations (U, IU, QD), require leading zeros (0.5 mg not .5 mg), electronic prescribing.

Dispensing errors
Examples

Wrong drug selected from LASA name pairs, wrong concentration of same drug, wrong patient label.

Prevention

Barcode verification at dispensing and bedside (BCMA), physical separation of LASA pairs, tall-man lettering.

Administration errors
Examples

Wrong route (oral dose given IV), wrong time (missed or duplicate dose), wrong infusion rate.

Prevention

Smart pump libraries with hard limits, bedside barcode scanning (BCMA), two-nurse independent double-checks for high-alert drugs.

Monitoring failures
Examples

Failure to check TDM levels (vancomycin, digoxin), failure to monitor INR during warfarin initiation.

Prevention

Structured TDM protocols, pharmacist-managed anticoagulation and antibiotic dosing services, electronic monitoring alerts.

Reconciliation errors
Examples

Home medications omitted on admission, unintentional drug duplication at discharge, wrong dose carried forward.

Prevention

Structured medication reconciliation at every care transition (admission, transfer, discharge) — a pharmacist-led process.

High-Alert Medications

The ISMP high-alert medications list ↗ identifies drug classes with the greatest potential for serious patient harm when errors occur. These drugs require additional safeguards beyond standard practice.

Drug / ClassError Type Most LikelyKey Safeguards
Insulin 10-fold dose errors; "units" misread as "0" Never abbreviate "units"; independent double-check; standardised sliding scales
Anticoagulants (heparin, warfarin, DOACs) Wrong dose, wrong drug, missed bridging Pharmacist-managed anticoagulation service; INR monitoring; renal dose check for DOACs
Concentrated KCl (≥2 mEq/mL) IV push administration causing cardiac arrest Remove from ward stock; require pharmacy preparation; smart pump library
Opioids Respiratory depression from dose errors or accumulation Opioid stewardship; dose conversion reference; PDMP check; naloxone co-prescribing
Neuromuscular blocking agents Administration to non-intubated patient Segregate storage; remove from ward stock; distinctive labelling
Methotrexate (oral) Daily dosing instead of weekly Label as "weekly dose"; patient and prescriber education; annual dose limit tracking
Chemotherapy agents Wrong dose (BSA calculation error), wrong cycle Pharmacy-only preparation; independent pharmacist double-check; 2-pharmacist sign-off
Hypertonic saline (NaCl 23.4%) Central line required; rapid infusion causes osmotic demyelination Pharmacy preparation only; infusion rate limits in smart pump library

Look-Alike / Sound-Alike (LASA) Drugs

LASA name confusions are a leading cause of serious medication errors. The ISMP confused drug names list ↗ is updated regularly and should be used to guide storage separation and labelling practices.

HumaLOG vs HumuLIN

Both insulins — different onset/duration

predniSONE vs predniSOLONE

Different potencies; paediatric dosing error risk

metforMIN vs metroNIDAZOLE

Completely different classes

CARBOplatin vs CISplatin

Different chemotherapy dosing — can be fatal

cloniDINE vs kloNOPIN (clonazepam)

Antihypertensive vs benzodiazepine

hydrALAZINE vs hydrOXYzine

Antihypertensive vs antihistamine

Tall-man lettering (capitalising distinguishing letters) is recommended by ISMP and FDA to highlight differences in similar-looking names.

Reporting Channels

Report medication errors and near misses to drive system improvement. Key channels:

ISMP MERP ↗

Medication Errors Reporting Program — voluntary, confidential, national database

FDA MedWatch ↗

Voluntary adverse event and error reporting to FDA — patients and professionals

AHRQ Common Formats ↗

Standardised error reporting formats for hospital patient safety organisations

The Joint Commission ↗

Sentinel event reporting for errors causing serious harm or death — required for accredited hospitals

Frequently asked questions

What is the most common type of medication error?
Wrong-dose errors are the most common category, followed by prescribing errors (wrong drug, wrong indication) and administration timing errors. Look-alike/sound-alike (LASA) mix-ups ↗ account for a large share of serious harm, as do 10-fold paediatric dosing errors — a major reason paediatric weight-based dosing requires independent double-checking. The ISMP high-alert medications list ↗ highlights the drug classes with highest harm potential.
What is a "near miss" and why should it be reported?
A near miss (also called a good catch or close call) is an error caught before reaching the patient. Near misses are more frequent than harm events and are critical for system learning. ISMP's Medication Errors Reporting Program (MERP) ↗ and the FDA MedWatch voluntary reporting programme ↗ accept near-miss reports. Institutional reporting (without punitive consequences) is the foundation of a Just Culture approach to medication safety ↗.
What are high-alert medications?
ISMP's high-alert medication list ↗ identifies drugs where errors are most likely to cause serious harm: insulin (hypoglycaemia from 10-fold errors), anticoagulants (ASHP anticoagulation resources ↗), concentrated electrolytes (KCl, NaCl 23.4%), opioids, and chemotherapy. Safeguards include independent double-checks, standardised order sets, smart infusion pump drug libraries with hard dose limits, and removal of concentrated KCl from ward stock.
How do smart infusion pumps prevent medication errors?
Smart infusion pumps (e.g., BD Alaris, B. Braun Infusomat) contain a drug library with concentration-specific soft limits (alert, can override) and hard limits (cannot override). Soft override rates are a key quality metric — high rates indicate the library needs calibration, not that the limits are too tight. The ISMP Smart Pump Technology programme ↗ provides implementation guidance. Library compliance rates (% infusions programmed from library) and override rates should be tracked and reported to pharmacy/quality committees.
What is the role of pharmacists in medication error prevention?
Pharmacists intercept errors at multiple stages: order verification (dose appropriateness, allergies, drug interactions — using tools like DailyMed ↗); renal and hepatic dose adjustment; barcode-assisted dispensing; unit-dose packaging; and medication reconciliation at care transitions. Studies show clinical pharmacists in ICU teams reduce preventable adverse drug events by 66–78%. The ASHP Medication Safety resource centre ↗ provides practical implementation tools.